EasySep™小鼠TIL（CD45）正选试剂盒
搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'
-
Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies STEMCELL and CDI will work together on progressive solutions for the life science tools market -
STEMCELL Technologies Brings Groundbreaking Intestinal and Brain Organoid Culture Tools to the Global Research Community STEMCELL Technologies Inc. has released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the lab -
STEMCELL Technologies Receives Government of Canada Support to Develop New Cell Isolation Technology that will Enable Advancements in the Study of the Immune Response to HIV and the Development of HIV Vaccines STEMCELL Technologies announced that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) will provide up to $1.5 million in financial support for the development of cell isolation technology that will further basic and translational HIV research as well as broader research in infectious disease -
STEMCELL Technologies Partners with the ATS to Offer Travel Scholarships STEMCELL Technologies has entered into a partnership with the American Thoracic Society (ATS) to offer the STEMCELL Technologies Scholarships to attend the ATS 2018 International Conference in San Diego, California -
STEMCELL Technologies Signs Exclusive Agreement with the Institute of Molecular Biotechnology to Commercialize Cerebral Organoid Culture Systems STEMCELL Technologies has entered into an exclusive licensing agreement with the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences for the rights to develop products for cerebral organoid culture -
hPSC Training Course: Reprogramming, Maintenance and Reversion to Naïve-Like State This three-day in-person course covers the reprogramming of somatic cells to induced pluripotent stem (iPS) cells, their maintenance in a feeder-free culture system and the reversion of primed state human pluripotent stem cells (hPSCs) to naïve-like state. -
Dr. Allen Eaves of STEMCELL Technologies Inc. named EY Entrepreneur Of The Year™ Pacific 2016 Dr. Allen Eaves, Chairman, President and Chief Executive Officer of STEMCELL Technologies, a global biotechnology company that supplies tools and services to enable life science research, is this year's Entrepreneur Of The Year Pacific winner
